Question follow-through · 87209
Omaveloxolone
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the reasons for the difference in availability of Omaveloxolone (Skyclarys) as a treatment for Friedrich's ataxia in (a) Scotland and (b) England a
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 3 Nov 2025
- Target answer date
- 11 Nov 2025
- Answer
- 11 Nov 2025 · 8 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Palliative Care: Children · 12 Nov 2025
- Department of Health and Social Care: Written Questions · 13 Nov 2025
- Mefloquine: Veterans · 12 Jan 2026
- Parkinson's Disease: Research · 12 Jan 2026
- Prostate Cancer: Screening · 9 Feb 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
3 Nov 2025
Question tabled
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the reasons for the difference in availability of Omaveloxolone (Skyclarys) as a treatment for Friedrich's ataxia in (a) Scotland and (b) England a
11 Nov 2025
Target answer date
Date supplied by the official written-questions record.
11 Nov 2025
Answer published
The Department has made no assessment of the reasons for the difference in the availability of omaveloxolone (Skyclarys) as a treatment for Friedrich's ataxia in Scotland, England, and Wales.Decisions on the availability of medicines are taken by the resp...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Palliative Care: Children
12 Nov 2025 · To ask the Secretary of State for Health and Social Care, if he will develop a plan to organise children’s palliative care services on a similar basis to the Operational Delivery Networks in use for neonatal care.
Department of Health and Social Care: Written Questions
13 Nov 2025 · To ask the Secretary of State for Health and Social Care, when he will answer Question 85056 on Prostate Cancer: Medical Treatments, tabled on 26 October for named day response by 30 October.
Mefloquine: Veterans
12 Jan 2026 · To ask the Secretary of State for Health and Social Care, what steps he has taken with the Secretary of State for Defence to ensure that NHS practitioners are informed of the vulnerability to suicidal ideation of veterans impacted by Lariam; and what step
Parkinson's Disease: Research
12 Jan 2026 · To ask the Secretary of State for Health and Social Care, with reference to the oral contribution of the Parliamentary Under-Secretary of State for Health and Social Care in the Westminster Hall debate on Parkinson's disease on 17 November 2025, col. 230W
Prostate Cancer: Screening
9 Feb 2026 · To ask the Secretary of State for Health and Social Care, what the average national unit cost is to the NHS for a local anaesthetic transperineal prostate biopsy, used in prostate cancer detection; and how that cost is calculated.
Prostate Cancer: Screening
9 Feb 2026 · To ask the Secretary of State for Health and Social Care, whether the recent review by the UK National Screening Committee of evidence on prostate cancer screening considered the potential value for money of adopting (a) shorter and (b) simplified MRI pro
Patients: Travel
9 Feb 2026 · To ask the Secretary of State for Health and Social Care, what plans he has for financial support for patients required to travel very long distances to access (a) stem cell transplants, (b) CAR-T immunotherapy and (c) other specialist treatments; what re
Naloxone
20 Feb 2026 · To ask the Secretary of State for Health and Social Care, if he will take steps to increase awareness of naloxone as an effective emergency treatment among (a) people at risk of opioid overdose and (b) people who may witness an opioid overdose.
Hemiplegia: Children
21 May 2026 · To ask the Secretary of State for Health and Social Care, if he will make it his policy to promote the drafting of NICE guidelines on early intervention by clinicians to treat infants diagnosed with Hemiplegia; and what recent assessment his department ha
Sodium Valproate and Surgical Mesh Implants: Compensation
29 Jun 2026 · To ask the Secretary of State for Health and Social Care, if he will take steps to supply the Patient Safety Commissioner, by 16 July 2026, with the information she has formally requested on (a) Government discussions, (b) actions taken across Government
Independent Review of Maternity Services at Nottingham University Hospitals NHS Trust
30 Jun 2026 · To ask the Secretary of State for Health and Social Care, if he will publish the (a) names and (b) roles of all senior clinicians who declined to take part in the Ockenden Review of Nottingham Maternity and Neonatal Services.
Osteoporosis: Diagnosis
9 Jul 2026 · To ask the Secretary of State for Health and Social Care, what steps he has taken to improve (a) awareness and (b) early diagnosis of osteoporosis before people suffer bone fractures as a result of the disease.